Search research articles
Contact Us
Filters
Showing results (101-110 of 119) with videos related to
Page
of 12
Sort By:
Headache
|
June 3, 2011
Effect of telcagepant on spontaneous ischemia in cardiovascular patients in a randomized study
Martin O Behm, Rebecca L Blanchard, M Gail Murphy, et al.
Cancer Chemotherapy and Pharmacology
|
February 22, 2005
Lack of effect of aprepitant on the pharmacokinetics of docetaxel in cancer patients
Peter Nygren, Kenneth Hande, Kevin J Petty, et al.
The British Journal of Dermatology
|
November 27, 2023
Diverse macrophage populations contribute to distinct manifestations of human cutaneous graft-versus-host disease
Johanna Strobl, Laura M Gail, Laura Krecu, et al.
Plos One
|
April 4, 2014
The gut of geographically disparate Ciona intestinalis harbors a core microbiota
Larry J Dishaw, Jaime Flores-Torres, Simon Lax, et al.
Clinical Pharmacokinetics
|
April 15, 2005
Pharmacokinetics of famotidine in infants
Larissa A Wenning, M Gail Murphy, Laura P James, et al.
Journal of Clinical Pharmacology
|
September 5, 2003
Lack of effect of aprepitant on digoxin pharmacokinetics in healthy subjects
Martin Feuring, Yih Lee, Laura H Orlowski, et al.
Cancer Chemotherapy and Pharmacology
|
August 25, 2010
Double-blind crossover study to assess potential differences in cytochrome P450 3A4 activity in healthy subjects receiving ondansetron plus dexamethasone, with and without aprepitant
S Aubrey Stoch, Cynthia Gargano, Jack Valentine, et al.
British Journal of Clinical Pharmacology
|
November 8, 2014
Characterizing the PK/PD relationship for inhibition of capsaicin-induced dermal vasodilatation by MK-3207, an oral calcitonin gene related peptide receptor antagonist
Chi-Chung Li, Steve Vermeersch, William S Denney, et al.
Journal of Clinical Pharmacology
|
October 15, 2013
Early-stage comparative effectiveness: randomized controlled trial with histamine inverse agonist MK-7288 in excessive daytime sleepiness patients
Hong Sun, Catherine MacLeod, Kate Mostoller, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
March 3, 2006
Metabolism and disposition of a potent and selective GABA-Aalpha2/3 receptor agonist in healthy male volunteers
Stacey L Polsky-Fisher, Stanley Vickers, Donghui Cui, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 119) with videos related to
Sort By:
Page
of 12
Headache
|
June 3, 2011
Effect of telcagepant on spontaneous ischemia in cardiovascular patients in a randomized study
Martin O Behm, Rebecca L Blanchard, M Gail Murphy, et al.
Cancer Chemotherapy and Pharmacology
|
February 22, 2005
Lack of effect of aprepitant on the pharmacokinetics of docetaxel in cancer patients
Peter Nygren, Kenneth Hande, Kevin J Petty, et al.
The British Journal of Dermatology
|
November 27, 2023
Diverse macrophage populations contribute to distinct manifestations of human cutaneous graft-versus-host disease
Johanna Strobl, Laura M Gail, Laura Krecu, et al.
Plos One
|
April 4, 2014
The gut of geographically disparate Ciona intestinalis harbors a core microbiota
Larry J Dishaw, Jaime Flores-Torres, Simon Lax, et al.
Clinical Pharmacokinetics
|
April 15, 2005
Pharmacokinetics of famotidine in infants
Larissa A Wenning, M Gail Murphy, Laura P James, et al.
Journal of Clinical Pharmacology
|
September 5, 2003
Lack of effect of aprepitant on digoxin pharmacokinetics in healthy subjects
Martin Feuring, Yih Lee, Laura H Orlowski, et al.
Cancer Chemotherapy and Pharmacology
|
August 25, 2010
Double-blind crossover study to assess potential differences in cytochrome P450 3A4 activity in healthy subjects receiving ondansetron plus dexamethasone, with and without aprepitant
S Aubrey Stoch, Cynthia Gargano, Jack Valentine, et al.
British Journal of Clinical Pharmacology
|
November 8, 2014
Characterizing the PK/PD relationship for inhibition of capsaicin-induced dermal vasodilatation by MK-3207, an oral calcitonin gene related peptide receptor antagonist
Chi-Chung Li, Steve Vermeersch, William S Denney, et al.
Journal of Clinical Pharmacology
|
October 15, 2013
Early-stage comparative effectiveness: randomized controlled trial with histamine inverse agonist MK-7288 in excessive daytime sleepiness patients
Hong Sun, Catherine MacLeod, Kate Mostoller, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
March 3, 2006
Metabolism and disposition of a potent and selective GABA-Aalpha2/3 receptor agonist in healthy male volunteers
Stacey L Polsky-Fisher, Stanley Vickers, Donghui Cui, et al.
Page
of 12